Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration

Sponsor
University of Ioannina (Other)
Overall Status
Recruiting
CT.gov ID
NCT05757674
Collaborator
(none)
130
2
41.3
65
1.6

Study Details

Study Description

Brief Summary

Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration

Condition or Disease Intervention/Treatment Phase
  • Other: Sample examination

Study Design

Study Type:
Observational
Anticipated Enrollment :
130 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration
Actual Study Start Date :
Jan 10, 2020
Anticipated Primary Completion Date :
Jun 20, 2023
Anticipated Study Completion Date :
Jun 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients

Patients

Other: Sample examination
No intervention will be performed

Control

Control

Other: Sample examination
No intervention will be performed

Outcome Measures

Primary Outcome Measures

  1. Intestinal microbiome profile [2022-2023]

    Intestinal microbiome profile

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Newly diagnosed neovascular age-related macular degeneration.
Exclusion Criteria:
  • Chronic gastrointestinal disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Ioannina Ioánnina Epirus Greece 451 10
2 University of Ioannina Ioánnina Epirus Greece 45110

Sponsors and Collaborators

  • University of Ioannina

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andreas Katsanos, Associate Professor of Ophthalmology, University of Ioannina
ClinicalTrials.gov Identifier:
NCT05757674
Other Study ID Numbers:
  • 20(7)-15/4/2020.
First Posted:
Mar 7, 2023
Last Update Posted:
Mar 7, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2023